A large study by Smolarz et al. (2019), analyzing the distribution of XRCC1, XRCC2, XPD, and RAD51 gene variants in 300 breast cancer patients and 300 controls, did not observe an association between variants determining poor DNA repair potential with cancer progression. This evidence concerns the gene XRCC1 and breast carcinoma.